Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis

Sourav Kundu, Manisha Yadav, Madhav Nilakanth Mugale, Bidya Dhar Sahu

Open source

DOI
10.1016/j.lfs.2026.124751
Published
2026-12
Container
Life Sciences
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lfs.2026.124751,
  title = {Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis},
  author = {Sourav Kundu and Manisha Yadav and Madhav Nilakanth Mugale and Bidya Dhar Sahu},
  year = {2026},
  journal = {Life Sciences},
  doi = {10.1016/j.lfs.2026.124751},
  url = {https://doi.org/10.1016/j.lfs.2026.124751}
}

RIS

TY  - JOUR
TI  - Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis
AU  - Sourav Kundu
AU  - Manisha Yadav
AU  - Madhav Nilakanth Mugale
AU  - Bidya Dhar Sahu
PY  - 2026
JO  - Life Sciences
DO  - 10.1016/j.lfs.2026.124751
UR  - https://doi.org/10.1016/j.lfs.2026.124751
ER  - 

APA

Kundu, S., Yadav, M., Mugale, M. N., & Sahu, B. D. (2026). Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124751

Source records